Supplementary Table S15 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

作者：Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips, James P. Long, Deep Singh, Nam Tran, Frank Tufaro, PJ Anand, Nicholas E. Navin, Sujit S. Prabhu, Jeffrey S. Weinberg, H. Benjamin Larman, Candelaria Gomez‐Manzano, Juàn Fueyo, Frederick F. Lang · 年份：2026 · DOI：10.1158/1078-0432.32714070 · 研究领域：Glioma Diagnosis and Treatment、Virus-based gene therapy research、Cancer Immunotherapy and Biomarkers

<p>Summary of adverse events related to Delta-24-RGD across all cohorts</p>